Fresh Tracks Therapeutics... (FRTX)
NASDAQ: FRTX
· Real-Time Price · USD
0.94
0.00 (0.00%)
At close: Feb 28, 2025, 12:19 PM
Fresh Tracks Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|
| Consulting Services Revenue | 794K | 404K | 27K |
| Consulting Services Revenue Growth | +96.53% | +1396.30% | n/a |
| Royalty Revenue | 100K | n/a | n/a |
| Royalty Revenue Growth | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.64M | 5.32M | 1.81M | 2.41M | 4.04M | 3M | 3.91M | 3.49M | 3.29M | 3.27M | 2.89M | 2.97M | 2.87M | 3.21M | 3.02M | 2.48M | 4.88M | 3.9M | 2.24M | 1.38M | 1.52M | 1.61M | 2.26M | 3.55M | 3.39M | 3.42M | 3.19M | 2.82M | 2.96M | 2.61M | 3.14M | 4.64M | 6.4M | 3.22M | 4.51M | 5.16M |
| Selling, General, and Administrative Revenue Growth | -69.14% | +194.25% | -25.10% | -40.22% | +34.51% | -23.18% | +12.11% | +5.96% | +0.64% | +13.08% | -2.56% | +3.42% | -10.65% | +6.29% | +21.77% | -49.17% | +25.12% | +74.00% | +62.94% | -9.29% | -5.78% | -28.79% | -36.36% | +4.93% | -0.91% | +7.02% | +13.31% | -4.89% | +13.35% | -16.75% | -32.27% | -27.52% | +98.51% | -28.57% | -12.65% | n/a |
| Research and Development Revenue | 10K | 627K | 609K | 1.94M | 2.6M | 3.56M | 1.86M | 6.01M | 3.12M | 10.22M | 8.84M | 6.05M | 4.56M | 1.28M | 2.71M | 2.66M | 6.63M | 3.34M | 759K | 3.88M | 2.56M | 2.5M | 3.6M | 3.66M | 4.45M | 3M | 3.64M | 3.3M | 2.98M | 2.6M | 2.3M | 2.48M | 2.84M | 2.13M | 2.46M | 3.64M |
| Research and Development Revenue Growth | -98.41% | +2.96% | -68.54% | -25.68% | -26.83% | +90.88% | -68.98% | +92.79% | -69.49% | +15.66% | +46.03% | +32.75% | +255.89% | -52.77% | +1.80% | -59.81% | +98.65% | +339.66% | -80.45% | +51.76% | +2.20% | -30.51% | -1.69% | -17.63% | +48.07% | -17.45% | +10.27% | +10.92% | +14.47% | +12.85% | -7.06% | -12.72% | +33.41% | -13.39% | -32.44% | n/a |